Research and Development
Phase II failure sees stock plunge and job cutbacks for Infinity Pharmaceuticals
June 15, 2016 Research and Development, Sales and Marketing AbbVie, infinity pharmaceuticals, non-Hodgkin lymphoma, trial failure
Sobi says US FDA approves higher dose of Orfadin to treat rare genetic disorder
June 15, 2016 Research and Development, Sales and Marketing US FDA, genetic disorder, regulation, sobi
FDA issues warnings on Janssen, AstraZeneca diabetes drugs
June 15, 2016 Research and Development, Sales and Marketing AstraZeneca, FDA, Janssen, farxiga, invokana
German Supreme Court grants Lilly appeal to block Alimta generics
June 15, 2016 Research and Development, Sales and Marketing Actavis, Alimta, Eli Lilly
Actelion says blood pressure drug Uptravi now available in Germany
June 15, 2016 Research and Development, Sales and Marketing Actelion, EU, blood pressure, product launch
Novartis says to develop antimalarial treatment with Medicines for Malaria Venture
June 15, 2016 Research and Development, Sales and Marketing Novartis, antimalarial drug, drug trial
Shire adds to gastrointestinal portfolio with Pfizer compound acquisition
June 14, 2016 Research and Development, Sales and Marketing Pfizer, Shire, acquisition, compound
Janssen says Imbruvica shows improved PFS in blood cancer in long-term effectiveness study
June 14, 2016 Manufacturing and Production, Research and Development Janssen, blood cancer, drug trial, imbruvica
Marinus says will stop developing adult focal onset seizure drug as Phase III trials fail; shares plunge
June 14, 2016 Manufacturing and Production, Research and Development Drug-Resistant Epilepsy, Marinus Pharmaceuticals, drug trial, ganaxolone
MSD insulin glargine biosimilar meets primary endpoint in late-stage trials
June 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing MSD, Merck, biosimilar, insulin, insuline glargine
FDA to review data on Amgen’s Humira biosimilar
June 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, FDA, Humira, biosimilar
Novo Nordisk says Victoza lowers risk of heart attacks in diabetes patients
June 14, 2016 Manufacturing and Production, Research and Development Novo Nordisk, Victoza, drug trial, type 2 diabetes
New COO appointed at X4 Pharmaceuticals
June 13, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Shire gets FDA breakthrough therapy designation for two rare disease drugs
June 13, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Breakthrough Therapy Designation, Shire, US FDA, rare disease, rare disease drugs
Lilly showcases positive late-stage data in diabetes treatments
June 13, 2016 Research and Development, Sales and Marketing diabetes, lilly
